Neuroprotective effects of testosterone upon cardiac sympathetic function in rats with induced heart failure

European Journal of Pharmacology

Volumn 619, Issue 1-3, 2009, Pages 68-74

  Han, Ying ^a   Fu, Lu ^a   Sun, Weiju ^a   Cao, Junxian ^a   Xie, Rongsheng ^a   Zhou, Ping ^a   Kang, Ningning ^a   Sun, Junfeng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Heart failure; Norepinephrine; Sympathetic nerve; Testosterone; Tyrosine hydroxylase

Indexed keywords

ANDROGEN RECEPTOR; FLUTAMIDE; ISOPRENALINE; NORADRENALIN; PLACEBO; TESTOSTERONE PROPIONATE; TYROSINE 3 MONOOXYGENASE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CASTRATION; CELL DENSITY; CONTROLLED STUDY; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RATE; HEART WEIGHT; HORMONE SUBSTITUTION; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYMPATHETIC FUNCTION; SYMPATHETIC NERVE; UPREGULATION; WESTERN BLOTTING;

ANDROGEN ANTAGONISTS; ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CASTRATION; FLUTAMIDE; GENE EXPRESSION REGULATION; HEART; HEART FAILURE; HEMODYNAMICS; MALE; MYOCARDIUM; NEUROPROTECTIVE AGENTS; NOREPINEPHRINE; ORGAN SIZE; RATS; RATS, WISTAR; REST; SYMPATHETIC NERVOUS SYSTEM; TESTOSTERONE; TYROSINE 3-MONOOXYGENASE;

EID: 69749086124     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.07.023     Document Type: Article

References (54)

1. Backs J., Haunstetter A., Gerber S.H., Metz J., Borst M.M., Strasser R.H., Kübler W., and Haass M. The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J. Mol. Cell. Cardiol. 33 (2001) 461-472
2. Benten W.P., Lieberherr M., Giese G., Wrehlke C., Stamm O., Sekeris C.E., Mossmann H., and Wunderlich F. Functional testosterone receptors in plama membranes of T cells. FASEB. J. 13 (1999) 123-133
3. Bialek M., Zaremba P., Borowicz K.K., and Czuczwar S.J. Neuroprotective role of testosterone in the nervous system. Pol. J. Pharmacol. 56 (2004) 509-518
4. Böhm M., LaRosée K., Schwinger R.H.G., and Erdmann E. Evidence of reduction of norepinephrine uptake sites in the failing human heart. J. Am. Coll. Cardiol. 25 (1995) 146-153
5. Bos R., Mougenot N., Médiani O., Vanhoutte P.M., and Lechat P. Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat. J. Pharmacol. Exp. Ther. 309 (2004) 1160-1166
6. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., Simon A.B., and Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311 (1984) 819-823
7. Dart A.M., Du X.J., and Kingwell B.A. Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc. Res. 53 (2002) 678-687
8. 2+ transport due to excess catecholamines. Cardiovasc. Drugs. Ther. 10 (1996) 231-238
9. Du X.J., and Dart A.M. Role of sympathoadrenergic mechanisms in arrhythmogenesis. Cardiovasc. Res. 43 (1999) 832-834
10. Du X.J., Cox H.S., Dart A.M., and Esler M.D. Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. Cardiovasc. Res. 43 (1999) 919-929
11. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A.A., Lambert G., and Kaye D.M. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93 (1996) 1667-1676
12. Esler M., and Kaye D. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail. Rev 5 (2000) 17-25
13. Falkenstein E., Tillman H.C., Christ M., Feuring M., and Wehling M. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol. Rev. 52 (2000) 513-555
14. Forger N.G., Hodges L.L., Roberts S.L., and Breedlove S.M. Regulation of motoneuron death in the spinal nucleus of bulblcavernosus. J. Neurobiol. 23 (1992) 1192-1203
15. 2B-adrenergic receptor mRNA Levels. Hypertension 25 (1995) 350-355
16. Grimm D., Elsner D., Schunkert H., Pfeifer M., Griese D., Bruckschlegel G., Muders F., Riegger G.A., and Kromer E.P. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc. Res. 37 (1998) 91-100
17. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc. Res. 28 (1994) 933-946
18. Hori Y., Uechi M., Ebisawa T., Yamano S., Yoshioka K., and Mutoh K. The influence of gender on cardiac fibrosis induced by sympathetic stimulation. Chin. J. Physiol. 51 (2008) 146-151
19. Hsieh Y.C., Yang S., Choudhry M.A., Yu H., Bland K.I., Schwacha M.G., and Chaudry I.H. Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H416-H423
20. Huang E.J., and Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24 (2001) 677-736
21. Jones T.J., Dunphy G., Milsted A., and Ely D. Testosterone effects on renal norepinephrine content and release in rats with different Y chromosomes. Hypertension 32 (1998) 880-885
22. Kawai H., Mohan A., Hagen J., Dong E., Armstrong J., Stevens S.Y., and Liang C.S. Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failure. Am. J. Physiol. Heart. Circ. Physiol. 278 (2000) H1708-H1716
23. Kaye D.M., Vaddadi G., Gruskin S.L., Du X.J., and Esler M.D. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ. Res. 86 (2000) e80-e84
24. 2-adrenoceptor subtypes. J. Pharmacol. Exp. Ther. 300 (2002) 43-49
25. Kienitz T., and Quinkler M. Testosterone and blood pressure regulation. Kidney Blood Press. Res. 31 (2008) 71-79
26. Knoll J., Miklya I., Knoll B., and Dalló J. Sexual hormones terminate in the rat: the significantly enhanced catecholaminergic/serotoninergic tone in the brain characteristic to the post-weaning period. Life. Sci. 67 (2000) 765-773
27. Kreusser M.M., Haass M., Buss S.J., Hardt S.E., Gerber S.H., Kinscherf R., Katus H.A., and Backs J. Injection of nerve growth factor into stellate ganglia improves norepinephrine reuptake into failing hearts. Hypertension 47 (2006) 209-215
28. 3H] norepinephrine from the rat vas deferens. Neurochem. Int. 7 (1985) 667-674
29. Liang C.S., Rounds N.K., Dong E., Stevens S.Y., Shite J., and Qin F. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial beta-adrenoceptor sensitivity in the ferret: normalization by antioxidant vitamins. Circulation 102 (2000) 96-103
30. Liang C.S., Yatani A., Himura Y., Kashiki M., and Stevens S.Y. Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and norepinephrine infusion. Am. J. Physiol. Heart. Circ. Physiol. 284 (2003) H1729-H1736
31. Liang C.S., Mao W.K., Iwai C., Fukuoka S., and Stevens S.Y. Cardiac sympathetic neuroprotective effect of desipramine in tachycardia-induced cardiomyopathy. Am. J. Physiol. Heart. Circ. Physiol. 290 (2006) H995-H1003
32. Mackins C.J., Kano S., Seyedi N., Schafer U., Reid A.C., Machida T., Silver R.B., and Levi R. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J. Clin. Invest. 116 (2006) 1063-1070
33. Malkin C.J., Pugh P.J., West J.N., van Beek E.J.R., Jones T.H., and Channer K.S. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur. Heart J. 27 (2006) 57-64
34. Malkin C.J., Jones T.H., and Channer K.S. Testosterone in chronic heart failure. Front. Horm. Res. 37 (2009) 183-196
35. Matsumoto A. Hormonally induced neuronal plasticity in the adult motoneurons. Brain Res. Bull. 44 (1997) 539-547
36. Melvin J.E., and Hamill R.W. Gonadal hormone regulation of neuro transmitter synthesizing enzymes in the developing hypogastric ganglion. Brain Res. 383 (1986) 38-46
37. Meusburger S.M., and Keast J.R. Testosterone and nerve growth factor have distinct but interacting effects on structure and neurotransmitter expression of adult pelvic ganglion cells in vitro. Neuroscience 108 (2001) 331-340
38. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., and Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N. Engl. J. Med. 334 (1996) 1349-1355
39. Partanen M., and Hervonen A. The effects of long-term castration on the histochemical demonstrable catecholamines in the hypogastric ganglion of the rat. J. Auton. Nerv. Syst. 1 (1979) 139-147
40. Peterziel H., Mink S., Schonert A., Becker M., Klocker H., and Cato A.C. Rapid signaling by androgen receptor in prostate cancer cells. Oncogene 18 (1999) 6322-6329
41. Pike C.J. Testosterone attenuates β-amyloid toxicity in cultured hippocampal neurons. Brain Res. 919 (2001) 160-165
42. Pool P.E., Covell J.W., Levitt M., Gibb J., and Braunwald E. Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure. Its role in the depletion of cardiac norepinephrine stores. Circ. Res. 20 (1967) 349--253
43. Pugh P.J., Jones T.H., and Channer K.S. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur. Heart. J. 24 (2003) 909-915
44. Pugh P.J., Jones R.D., West J.N., Jones T.H., and Channer K.S. Testosterone treatment for men with chronic heart failure. Heart 90 (2004) 446-447
45. Push P.J., English K.M., Jones T.H., and Channer K.S. Testosterone: a natural tonic for the failing heart?. Q. J. Med. 93 (2000) 689-694
46. Qin F., Vulapalli R.S., Stevens S.Y., and Liang C.S. Loss of cardiac sympathetic neurotransmitters in heart failure and norepinephrine infusion is associated with reduced NGF. Am. J. Physiol. Heart. Circ. Physiol. 282 (2002) H363-H371
47. Remiao F., Carmo H., Carvalho F., and Bastos M.L. Copper enhances isoproterenol toxicity in isolated rat cardiomyocytes: effects on oxidative stress. Cardiovasc. Toxicol. 1 (2001) 195-204
48. Samy T.S., Zheng R., Matsutani T., Rue L.W., Bland K.I., and Chaudry I.H. Mechanism for normal splenic T lymphocyte functions in proestrus females after trauma: enhanced local synthesis of 17-estradiol. Am. J. Physiol. Cell. Physiol. 285 (2003) C139-C149
49. Shang Y., and Dluzen D.E. Castration increases nisoxetine-evoked norepinephrine levels in vivo within the olfactory bulb of male rats. Neurosci. Lett. 328 (2002) 81-84
50. Teerlink J.R., Pfeffer J.M., and Pfeffer M.A. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ. Res. 75 (1994) 105-113
51. Tirassa P., Thiblin I., Agren G., Vigneti E., Aloe L., and Stenfors C. High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J. Neurosci. Res. 47 (1997) 198-207
52. Tsang S., Wu S., Liu J., and Wong T.M. Testosterone protects rat hearts against ischaemic insults by enhancing the effects of alpha(1)-adrenoceptor stimulation. Br. J. Pharmacol. 153 (2008) 693-709
53. Vicencio J.M., Ibarra C., and Estrada M. Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology 147 (2006) 1386-1395
54. Zhou P., Fu L., Pan Z., Ma D., Zhang Y., Qu F., Guo L., Cao J., Gao Q., and Han Y. Testosterone deprivation by castration impairs expression of voltage-dependent potassium channels in rat aorta. Eur. J. Pharmacol. 593 (2008) 87-91